The DNA mismatch repair (MMR) system is primarily responsible for purging newly synthesized DNA of errors incurred during semi-conservative replication. Lesion recognition is initially carried out by one of two heterodimeric protein complexes, MutSa or MutSb. While the former, comprised of MSH2 and MSH6, recognizes mispairs as well as short (1 -2 nucleotide) insertions/deletions (IDLs), the latter, made up of MSH2 and MSH3, is primarily responsible for recognizing 2 -6 nucleotide IDLs. As most of the functional information on these heterodimers is derived from in vitro studies, it was of interest to study the in vivo consequences of a lack of MutSa. To this end, Big Blue TM mice, that carry a lacI + transgenic l shuttlephage mutational reporter, were crossed with Msh6 7/7 mice to evaluate the specific contribution of MutSa to genome integrity. Consistent with the importance of MutSa in lesion surveillance, small intestine epithelial cell DNA derived from lacI + Msh6 7/7 mice exhibited striking increases (average of 41-fold) in spontaneous mutant frequencies. Furthermore, the lacI gene mutation spectrum was dominated by G:C to A:T transitions, highlighting the critical importance of the MutSa complex in suppressing this frequently observed type of spontaneous mutation. Oncogene (2002 Oncogene ( ) 21, 7126 -7130. doi:10.1038 Keywords: DNA mismatch repair; Msh6; lacI; transgenic shuttle-phage; small intestinal epithelium; Big Blue TM DNA mismatch repair (MMR) has evolved to correct errors introduced during the process of DNA replication and to prevent mutations arising from specific types of base damage. The MMR mechanism, initially described in bacteria (Modrich, 1991; Modrich and Lahue, 1996) is highly conserved, having a variety of orthologs in eukaryotic cells (Kolodner, 1996) . In mammalian MMR, recognition of mispaired bases or insertion deletion loops (IDLs) is mediated by two heterodimeric protein complexes with overlapping functions (Acharya et al., 1996; Buermeyer et al., 1999; Kolodner, 1996) . MutSa, consisting of MSH2 and MSH6, supports the repair of base mismatches, single nucleotide (nt) insertions or deletions and to a lesser extent larger IDLs (Edelmann et al., 1997; Umar et al., 1998) ; while MutSb, composed of MSH2 and MSH3, appears to be primarily involved in the repair of IDLs from 2 -6 nts and, to a lesser degree, single base loops (Palombo et al., 1996) . One of at least three different heterodimeric MutL complexes (Aquilina and Bignami, 2001; Wang et al., 1999) , of which MutLa (MLH1:PMS2) appears to be the most important in mutation prevention, then associates with either MutSa or b to complete the second step in the MMR process (Kolodner, 1996) .
Gene targeting experiments in mice have proven very useful in assessing the contribution of MMR components to genomic stability. For example, mice lacking MSH2 (de Wind et al., 1995; Reitmair et al., 1995) , MSH6 (de Wind et al., 1999; Edelmann et al., 1997) , MLH1 (Baker et al., 1996; Edelmann et al., 1996) or PMS2 (Baker et al., 1995) , but not MSH3 (de Wind et al., 1999; Edelmann et al., 2000) are predisposed to cancer. In keeping with the important roles of MutSa and MutSb, mice with a combined deficiency in both MSH3 and MSH6 have a tumor spectrum similar to that of MSH2 deficient mice (de Wind et al., 1995; de Wind et al., 1999; Edelmann et al., 2000; Reitmair et al., 1995) .
Transgenic mice engineered for mutation detection have allowed exploration of the consequences of MMR deficiency at the single gene level (Andrew et al., 1997; Narayanan et al., 1997) . The incorporation of a passive, retrievable, forward mutation reporter gene such as lacI into a murine host makes possible the collection of tissue-specific mutant frequencies and mutation spectra (Mirsalis et al., 1993) . We used the lacI based mutation detection system, BC-1, previously to evaluate mutagenesis in mice lacking specific MMR components (Andrew et al., 1997 (Andrew et al., , 2000 Baross-Francis et al., 2001) . In order to similarly gain insight into the relative importance of MSH6 in the preservation of genomic integrity in small intestinal epithelial cells, we crossed mice deficient for MSH6 with Big Blue TM (Stratagene), a murine strain that carries a transgenic lacI + l shuttle phage (Dycaico et al., 1994) . Our results underscore the critical importance of MSH6 in suppressing spontaneous transition mutations, particularly G:C to A:T changes within this target gene.
Elevated lacI mutant frequencies in Msh6
7/7 DNA Mutant frequencies were determined for DNA from small intestine epithelial cells from MSH6-deficient and wildtype control mice using the Big Blue TM lacIbased transgenic system (Table 1) . We chose to study small intestinal cells as this is a site of tumorigenesis in Msh6 7/7 mice, and also as it is a tissue having a high turnover rate. The latter ensures that premutagenic DNA lesions have the opportunity to be fixed within progeny cells. MSH6-deficient mice (Table  1) exhibited on average a 41-fold increase in lacI mutant frequency over controls (Table 1) . Analysis of the mutation spectra of randomly selected lacI mutants derived from MSH6-deficient mice revealed a high incidence of recurrently isolated mutations (average 37%) ( Table 1) . Correction for the possible contribution of clonal mutations, enabled by sequencing multiple mutants per mouse (see below), lowered the average lacI mutant frequency for Msh6 7/7 small intestinal cells from 67610 75 to 41610 75 . Mutant frequencies from MSH6-deficient mice showed significantly higher variability, both in terms of the incidence of recurrently identified mutations and mutation frequencies, than lacI mutants isolated from small intestinal epithelial cells of Mlh1 7/7 , BC-1 mice (Baross-Francis et al., 2001) . The mutational induction in the small intestinal epithelium of Msh6 7/7 mice points to a critical role for MSH6 in mediating the recognition and repair of pre-mutagenic lesions in this tissue.
Mutation spectra
The mutation spectrum of Msh6 7/7 small intestinal epithelial cell DNA was determined by characterizing 12 -17 unique lacI mutations per small intestine (Table  2) . It is usual to be conservative and remove recurrent lacI mutations within individual mice from the analysis to prevent the potential influence of clonal mutations on the mutation spectra. Such a spectrum is shown in Table 2 . It should be noted, however, that 'hot spots', lacI mutations (all G:C to A:T changes) recurring in different mice within the experimental cohort, were found at 14 different locations. For example, G56 in the lacI gene was observed to be mutated to A in all the mice, and coding strand sites C42, and G381 were mutated in four out of five mice to T, and A, respectively. Interestingly, these sites are also amongst those most often reported to be mutated in the transgenic lacI database (Cariello and Gorelick, 1996) . It is not clear at this time either to what extent the mutations at these sites arose independently from one another, or which mutational mechanism(s) accounts for these lacI 'hot spots'. Given the presence of these 'hot spots' and the high percentage of clonality, it is possible that the removal of clonal mutations from our analysis resulted in a distortion of the spectrum. The latter was therefore also determined (Edelmann et al., 1997) were crossed with Big Blue TM mice (Stratagene, La Jolla, CA, USA) carrying the lacI + transgene. All mice were on a C57BL/6 background, were viral antibody-free, and maintained in a barrier facility according to University of Calgary guidelines. Genotyping was carried out by PCR using DNA from mouse tail tips. Msh6 genotyping has been described previously (Edelmann et al., 1997) and lacI was detected using primers711 (GACACCATCGAATGGTGC) and 487 (CTGGTCAGAGACATCAAG). Mice were euthanized by CO 2 inhalation or cervical dislocation and their small intestine epithelial cells isolated as described previously (Baross-Francis et al., 2001) . Mutant frequencies were determined for DNA using the Big Blue TM lacI-based transgenic system according to the manufacturer's instructions. pfu=plaque forming unit; AVG=average; SD=standard deviation; ND=not determined Transition mutations predominate in Msh6 7/7 mice SC Mark et al without correction for clonality, with the result being that the total number of mutants rose from 81 to 131, the transitions went up to 90% (most of which are G:C?A:T transitions) and the percentage in the other categories went down (since all the clonal mutations are transitions). A Monte Carlo simulation of the hypergeometric test (Cariello et al., 1994) was performed on the two spectra, using the number of mutants of each category as input, and there was no significant difference between them (P=0.97).
MSH6 (through MutSa) supports the repair of base mismatches, single nucleotide (nt) insertions/deletions and to a lesser extent larger IDLs in vitro, thus one would not expect to see larger IDLs reflected in the in vivo mutation spectrum of MSH6-deficient mice since MutSb is still present and is primarily involved in the repair of IDLs and, to a lesser degree, single base loops (Genschel et al., 1998) . This is reflected in the data presented in Table 2 . Base transitions clearly dominated the mutation spectra of MSH6-deficient mice (accounting for 84% of the unique mutations), with G:C to A:T transitions accounting for 73% (59 out of 68) of these mutations. Of the 59 G:C to A:T mutations isolated, 58% were at CpG sites, (3% of the total CpG sites), and 42% were at non-CpG sites. Furthermore, of the mutations occurring at non-CpG sites, 56% (14 of 25) of these changes fell at the 3' G of GpG dinucleotides (1.5% of the total GpG sites), sites commonly mutated following exposure to SN1 alkylating agents, such as MNU Andrew et al., 1998) . Consistent with previous evidence (Jiricny and Nystrom-Lahti, 2000) , these results suggest that one of the primary in vivo roles of MSH6 is the recognition and correction of G:T mispairs. The remainder of the mutation spectrum was comprised primarily of A:T to G:C transitions (11%); various transversions (7%), with G:C to T:A being the most frequent; and +1/71 insertions/deletions (7%), with 71 deletions being the most common. Interestingly, G:C to T:A, and 71, are also the most frequent transversions, and insertions/deletions, respectively, that are seen in MMR-proficient lacI transgenic rodents (Zhang et al., 2001) .
The increased lacI mutant frequencies in MSH6-deficient intestinal epithelial cells was consistent with the observation that Msh6 7/7 and Msh6 7/7 / Apc 1638N +/7 mice display an increased incidence of spontaneous tumors relative to MMR proficient hosts (Edelmann et al., 1997; Kuraguchi et al., 2001) , and the recognized role of MSH6 in the maintenance of genomic stability (Jiricny and Nystrom-Lahti, 2000 , 1998) . This was intriguing, as MSH2 and MLH1 are obligate partners in the initial stages of MMR. Loss of either of these proteins would be predicted to eliminate all MMR activity. In contrast, in the absence of MSH6, MutSb-mediated damage recognition and repair would still be possible. One explanation for this apparent discrepancy is that mutational analysis of both MSH2 and MLH1-deficient tissues we carried out previously used the BC71 lacI transgenic system (Andrew et al., 1996) , whereas the current data used the C57BL/6 Big Blue TM system. Thus, it is conceivable that differences in chromosomal context of the two lacI reporter systems and/or differences in the genetic backgrounds of the mice account for the mutant frequency differences observed.
The mutation spectrum of Msh6 7/7 small intestinal epithelial cells demonstrated a lower proportion of non-G:C to A:T mispairs than did MLH-1 deficient mice (20 vs 34 as a percentage of base / base mispair mutations, respectively). This may have been due to several factors, including differences in the genetic backgrounds of the MMR deficient mice as mentioned above, differences in the chromatin context of the lacI reporter genes and the ability of MutSb to compensate for a loss of MSH6 in vivo through preserved recognition of non-G:T mispairs. In keeping with this, mispair recognition by MSH3 was demonstrated in an experiment where addition of a single functional copy of the MSH3 gene to an MSH3/MSH6-deficient background brought about the repair of both transitions and transversions (Umar et al., 1998) . Our results suggest that MutSb might play a minor role in suppressing non-G:T mispairs. MSH6-deficient small intestinal epithelial cells had a lower proportion of +1/ 71 IDLs as compared to MLH-1 deficient mice (Baross-Francis et al., 2001) , consistent with the ability of MSH3 (via MutSb) to recognize some proportion of these lesions in vivo. In keeping with this, Kuraguchi et al. (2001) found only a small induction in +1/71 Isolation of DNA, and transgenic lambda-phage rescue procedures were as described in the Big Blue TM protocol (Stratagene, La Jolla, CA, USA). Blue plaques were confirmed by replating and sequenced as previously described (Andrew et al., 1996; Baross-Francis et al., 2001) . Sequencing was carried out at the University of Calgary, or the Center for Molecular Medicine and Therapeutics, University of British Columbia sequencing facilities. lacI gene mutations were identified using Multalin software (Corpet, 1988) Transition mutations predominate in Msh6 7/7 mice SC Mark et al IDLs in the mutation spectra of the APC locus in Msh6
Apc 1638N+/7 -mice. However, given the mutant frequency elevation in MSH6-deficient mice, and the percentage of one base IDLs observed, it is clear that the majority of +1/71 events remain unrepaired in the absence of MutSa.
The predominance of G:C to A:T transitions (73%) (Table 2) confirmed the requirement for MSH6 (and hence MutSa) in the recognition of specific lesions leading to this mutational class. A spectrum dominated by G:C to A:T mismatches would be predicted from previous in vitro and in vivo data on MSH6 deficiency (Jiricny and Nystrom-Lahti, 2000) . Indeed, high binding affinity of MutSa for G:T mispairs is considered to be a defining characteristic of this complex (Palombo et al., 1995) . In keeping with this, nuclear extracts from cells over-expressing MSH3, which results in the degradation of MSH6, lost binding activity for G:T mispairs in bandshift experiments (Drummond et al., 1997; Marra et al., 1998) . Also, Kuraguchi et al. (2001) , in defining the APC locus mutations in Msh6 7/7 /Apc 1638N+/7 gastrointestinal epithelial tumors, noted the predominance of G:C to A:T events (85%). Thus, using a completely different assay system (forward assay, under selection) this study arrived at a result similar to that reported herein (forward assay, passive). Interestingly, despite the fact the APC gene is transcribed while the lacI locus is silent (Cosentino and Heddle, 2000) , the two mutational spectra are similar.
The major causes of G:C to A:T transitions in mammals include: the generation of G:T (or C:A) mispairs during semi-conservative DNA replication, recombination events, deamination of 5-methylC at CpG sites, deamination of non-methylated cytosines to uracil, and methylation of the O 6 position of guanine which can lead to thymine misincorporation by DNA polymerases (Marra and Schar, 1999) . With respect to the relative importance of CpG sites in determining the mutational spectrum, we found that of all G:C to A:T transitions, 42% were at non-CpG sites. Given the substantial mutant frequency elevations in the MSH6-deficient mice, this result suggested that spontaneous deaminations of 5'-methycytosine residues was not the only pre-mutagenic mechanism involved in generating the high proportion of G:C to A:T changes observed. In this respect, it should be noted that a transgenic mouse containing a lacI gene purged of 86% of its CpG sites did not exhibit a substantial reduction in spontaneous mutation rate (Skopek et al., 1998) . Furthermore, Monroe et al. (2001) concluded that tissue-to-tissue variation in spontaneous mutant frequencies of lacI transgenic rats could not be correlated with methylation status of CpG sites in the transgene. Together, the results suggest that G:C base pairs are prone to damage that results in G:C to A:T transitions and that multiple mutagenic mechanisms are likely to have a role in their genesis.
Given the crucial role for MSH6 in mutation prevention in the intestinal epithelial cells, it is surprising how infrequently germline mutations of human MSH6 have been reported in HNPCC. However, a correlation between mutations in MSH6 and human cancers has been complicated by the inability to use microsatellite instability at repetitive sequences as a diagnostic tool (Jiricny and NystromLahti, 2000) . Despite the lack of simple diagnostic tools to identify MSH6 mutations, there has been a steady increase in the number of germline mutations of this gene reported to the database of the International Collaborative Group on HNPCC (Kolodner et al., 1999; Peltomaki, 2001) . Interestingly, patients with heritable defects in MSH6 tend to develop a cancer syndrome distinct from that of classical HNPCC, with tumors being more frequently found in extra-colonic tissues, including endometrium, and to a lesser extent small bowel, ureter and renal pelvis (Peltomaki, 2001) . It may be speculated that a G:C to A:T transition mutation-rich spectrum resulting from a loss of MSH6 might, at least in part, account for the observed difference in tumor spectrum.
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